Evidence map›Paper›PMID 41249829›Full record

ArticleNPJ precision oncology2025

Multiclass machine learning models for molecular subtype identification of pediatric low-grade glioma using bi-institutional MRIs for precision medicine.

Khashayar Namdar, Matthias W Wagner, Min Sheng, Peter Dirks, Kristen W Yeom, Cynthia Hawkins, Uri Tabori, Birgit B Ertl-Wagner, Farzad Khalvati

Abstract read
In one paragraph

Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Khashayar NamdarDepartment of Diagnostic & Interventional Imaging, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.
Matthias W WagnerDepartment of Diagnostic & Interventional Imaging, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.
Min ShengDepartment of Diagnostic & Interventional Imaging, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.
Peter DirksDivision of Neurosurgery, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.
Kristen W YeomDepartment of Radiology, Phoenix Children's Hospital, Phoenix, AZ, USA.
Cynthia HawkinsDepartment of Paediatric Laboratory Medicine, Division of Pathology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Uri TaboriDepartment of Neurooncology, The Hospital for Sick Children, Toronto, ON, Canada.
Birgit B Ertl-WagnerDepartment of Diagnostic & Interventional Imaging, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.
Farzad KhalvatiDepartment of Diagnostic & Interventional Imaging, The Hospital for Sick Children (SickKids), Toronto, ON, Canada. farzad.khalvati@utoronto.ca.

Funding

CIHR 184015
6 · The paper itself

Abstract

Pediatric Low-Grade Glioma (pLGG) is the most common pediatric brain tumor, and radiomics-based machine learning (ML) models have shown promise in identifying BRAF fusion and BRAF p.V600E mutation. This bicentric retrospective study included 495 children diagnosed between 1999 and 2023. The local hospital dataset comprised Magnetic Resonance Imaging (MRI) scans of patients with BRAF fusion (n = 190), BRAF p.V600E mutation (n = 95), FGFR1 (n = 25), and other molecular subtypes (n = 144), while an external dataset included BRAF fusion (n = 32) and BRAF p.V600E mutation (n = 9) cases. Radiomics features were extracted from Fluid-Attenuated Inversion Recovery images, and Random Forest classifiers were trained using Monte Carlo data splits and leave-one-out validation. The best-performing model achieved an average one-vs-the-rest area under receiver operating characteristic curve of 0.819 (95% confidence interval [0.791, 0.848]). This study highlights the potential of radiomics-based ML models for molecular subtype differentiation in pLGG, with per-patient predictions enabling outlier identification and subgroup performance evaluation.

Identifiers

PMID41249829
PMCPMC12624134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.